As part of a clinical trial, the National Center for Tumor Diseases (NCT/UCC) Dresden is now offering patients with ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 ...

Several states have effectively declared war on medical progress. Lawmakers in Iowa, Idaho, Texas, and Kentucky have introduced bills that would ban or restrict vaccines that use messenger RNA, or ...

The approach was tested at the Memorial Sloan Kettering Cancer Center, New York City, in an early clinical trial involving 16 patients with pancreatic cancer, which had a 5-year survival rate of 13%.

Cancer vaccines harness the ... Balachandran is conducting small trials with human patients to develop a vaccine for a deadly ...

OSE shared survival data behind its therapeutic vaccine’s pancreatic cancer win, ... France invests €1.3M into novel mRNA project led by OSE Immunotherapeutics .

Health Minute” brings original health care and health policy reporting from the KFF Health News newsroom to the airwaves each week.

“It came as a surprise that our approach works so well,” Lu said. In preclinical (non-human) studies, the vaccine completely ...

Personalized mRNA vaccine to treat aggressive pancreatic cancer in clinical trial. May 11, 2023. ... Pancreatic cancer vaccines eliminate disease in preclinical models. Your friend's email.